%PDF- %PDF-
Mini Shell

Mini Shell

Direktori : /var/www/html/shaban/duassis/api/public/storage/q8q7nfc/cache/
Upload File :
Create Path :
Current File : //var/www/html/shaban/duassis/api/public/storage/q8q7nfc/cache/295e4e1559a94f4361fca359c5a9a2a6

a:5:{s:8:"template";s:7286:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<title>{{ keyword }}</title>
<link href="//fonts.googleapis.com/css?family=Lato%3A300%2C400%7CMerriweather%3A400%2C700&amp;ver=5.4" id="siteorigin-google-web-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}footer,header,nav{display:block}a{background-color:transparent}svg:not(:root){overflow:hidden}button{color:inherit;font:inherit;margin:0}button{overflow:visible}button{text-transform:none}button{-webkit-appearance:button;cursor:pointer}button::-moz-focus-inner{border:0;padding:0}html{font-size:93.75%}body,button{color:#626262;font-family:Merriweather,serif;font-size:15px;font-size:1em;-webkit-font-smoothing:subpixel-antialiased;-moz-osx-font-smoothing:auto;font-weight:400;line-height:1.8666}.site-content{-ms-word-wrap:break-word;word-wrap:break-word}html{box-sizing:border-box}*,:after,:before{box-sizing:inherit}body{background:#fff}ul{margin:0 0 2.25em 2.4em;padding:0}ul li{padding-bottom:.2em}ul{list-style:disc}button{background:#fff;border:2px solid;border-color:#ebebeb;border-radius:0;color:#2d2d2d;font-family:Lato,sans-serif;font-size:13.8656px;font-size:.8666rem;line-height:1;letter-spacing:1.5px;outline-style:none;padding:1em 1.923em;transition:.3s;text-decoration:none;text-transform:uppercase}button:hover{background:#fff;border-color:#24c48a;color:#24c48a}button:active,button:focus{border-color:#24c48a;color:#24c48a}a{color:#24c48a;text-decoration:none}a:focus,a:hover{color:#00a76a}a:active,a:hover{outline:0}.main-navigation{align-items:center;display:flex;line-height:1}.main-navigation:after{clear:both;content:"";display:table}.main-navigation>div{display:inline-block}.main-navigation>div ul{list-style:none;margin:0;padding-left:0}.main-navigation>div li{float:left;padding:0 45px 0 0;position:relative}.main-navigation>div li:last-child{padding-right:0}.main-navigation>div li a{text-transform:uppercase;color:#626262;font-family:Lato,sans-serif;font-size:.8rem;letter-spacing:1px;padding:15px;margin:-15px}.main-navigation>div li:hover>a{color:#2d2d2d}.main-navigation>div a{display:block;text-decoration:none}.main-navigation>div ul{display:none}.menu-toggle{display:block;border:0;background:0 0;line-height:60px;outline:0;padding:0}.menu-toggle .svg-icon-menu{vertical-align:middle;width:22px}.menu-toggle .svg-icon-menu path{fill:#626262}#mobile-navigation{left:0;position:absolute;text-align:left;top:61px;width:100%;z-index:10}.site-content:after:after,.site-content:before:after,.site-footer:after:after,.site-footer:before:after,.site-header:after:after,.site-header:before:after{clear:both;content:"";display:table}.site-content:after,.site-footer:after,.site-header:after{clear:both}.container{margin:0 auto;max-width:1190px;padding:0 25px;position:relative;width:100%}@media (max-width:480px){.container{padding:0 15px}}.site-content:after{clear:both;content:"";display:table}#masthead{border-bottom:1px solid #ebebeb;margin-bottom:80px}.header-design-2 #masthead{border-bottom:none}#masthead .sticky-bar{background:#fff;position:relative;z-index:101}#masthead .sticky-bar:after{clear:both;content:"";display:table}.sticky-menu:not(.sticky-bar-out) #masthead .sticky-bar{position:relative;top:auto}#masthead .top-bar{background:#fff;border-bottom:1px solid #ebebeb;position:relative;z-index:9999}#masthead .top-bar:after{clear:both;content:"";display:table}.header-design-2 #masthead .top-bar{border-top:1px solid #ebebeb}#masthead .top-bar>.container{align-items:center;display:flex;height:60px;justify-content:space-between}#masthead .site-branding{padding:60px 0;text-align:center}#masthead .site-branding a{display:inline-block}#colophon{clear:both;margin-top:80px;width:100%}#colophon .site-info{border-top:1px solid #ebebeb;color:#626262;font-size:13.8656px;font-size:.8666rem;padding:45px 0;text-align:center}@media (max-width:480px){#colophon .site-info{word-break:break-all}}@font-face{font-family:Lato;font-style:normal;font-weight:300;src:local('Lato Light'),local('Lato-Light'),url(http://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh7USSwiPHA.ttf) format('truetype')}@font-face{font-family:Lato;font-style:normal;font-weight:400;src:local('Lato Regular'),local('Lato-Regular'),url(http://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjx4wWw.ttf) format('truetype')}@font-face{font-family:Merriweather;font-style:normal;font-weight:400;src:local('Merriweather Regular'),local('Merriweather-Regular'),url(http://fonts.gstatic.com/s/merriweather/v21/u-440qyriQwlOrhSvowK_l5-fCZJ.ttf) format('truetype')}@font-face{font-family:Merriweather;font-style:normal;font-weight:700;src:local('Merriweather Bold'),local('Merriweather-Bold'),url(http://fonts.gstatic.com/s/merriweather/v21/u-4n0qyriQwlOrhSvowK_l52xwNZWMf_.ttf) format('truetype')} </style>
 </head>
<body class="cookies-not-set css3-animations hfeed header-design-2 no-js page-layout-default page-layout-hide-masthead page-layout-hide-footer-widgets sticky-menu sidebar wc-columns-3">
<div class="hfeed site" id="page">
<header class="site-header" id="masthead">
<div class="container">
<div class="site-branding">
<a href="#" rel="home">
{{ keyword }}</a> </div>
</div>
<div class="top-bar sticky-bar sticky-menu">
<div class="container">
<nav class="main-navigation" id="site-navigation" role="navigation">
<button aria-controls="primary-menu" aria-expanded="false" class="menu-toggle" id="mobile-menu-button"> <svg class="svg-icon-menu" height="32" version="1.1" viewbox="0 0 27 32" width="27" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<path d="M27.429 24v2.286q0 0.464-0.339 0.804t-0.804 0.339h-25.143q-0.464 0-0.804-0.339t-0.339-0.804v-2.286q0-0.464 0.339-0.804t0.804-0.339h25.143q0.464 0 0.804 0.339t0.339 0.804zM27.429 14.857v2.286q0 0.464-0.339 0.804t-0.804 0.339h-25.143q-0.464 0-0.804-0.339t-0.339-0.804v-2.286q0-0.464 0.339-0.804t0.804-0.339h25.143q0.464 0 0.804 0.339t0.339 0.804zM27.429 5.714v2.286q0 0.464-0.339 0.804t-0.804 0.339h-25.143q-0.464 0-0.804-0.339t-0.339-0.804v-2.286q0-0.464 0.339-0.804t0.804-0.339h25.143q0.464 0 0.804 0.339t0.339 0.804z"></path>
</svg>
</button>
<div class="menu-menu-1-container"><ul class="menu" id="primary-menu"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-20" id="menu-item-20"><a href="#">About</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-165" id="menu-item-165"><a href="#">Blog</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-24" id="menu-item-24"><a href="#">FAQ</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-22" id="menu-item-22"><a href="#">Contacts</a></li>
</ul></div> </nav>
<div id="mobile-navigation"></div>
</div>
</div>
</header>
<div class="site-content" id="content">
<div class="container">
{{ text }}
<br>
{{ links }}
</div>
</div>
<footer class="site-footer " id="colophon">
<div class="container">
</div>
<div class="site-info">
<div class="container">
{{ keyword }} 2021</div>
</div>
</footer>
</div>
</body>
</html>";s:4:"text";s:22643:"Black Diamond Therapeutics, Inc., a biotechnology company, discover and develops small molecule, tumor-agnostic therapies. and NEW YORK, May 17, 2021 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, MasterKey During the day, the stock rose to $13.35 an The company belongs in the Biotechnology industry, Healthcare sector and … LOCATIONS. (AP) _ Black Diamond Therapeutics, Inc. (BDTX) on Friday reported a loss of $30.3 million in its first quarter. About Black DiamondBlack Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, MasterKey therapies. Black Diamond targets undrugged mutations in patients with genetically defined cancers. Its lead product candidate is BDTX-189, an irreversible small molecule inhibitor that is designed to block the function of family of oncogenic proteins defined by driver mutations across a range of tumor types, and which affect the epidermal … Black Diamond Therapeutics Inc stock is down -65.90% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives BDTX stock a score of 29 out of a possible 100.. That rank is mainly influenced by a short-term technical score of 0. A "buy" rating indicates that analysts believe BDTX will outperform the market and that investors should add to their positions of Black Diamond Therapeutics. Black Diamond Therapeutics Inc. (NASDAQ:BDTX)’s average true range (ATR) indicator is currently reading 1.73. 25 Health Sciences Drive, Suite 105 Real time Black Diamond Therapeutics, Inc. (BDTX) Institutional Ownership Latest Stock Picks ... Stock Market News; Retirement Getting Started. The stock spiked 47.28% in intraday trading to $27.77 this Friday, May 14, hitting a weekly high. Black Diamond Therapeutics shares (BDTX) are listed on the NASDAQ and all prices are listed in US Dollars. Black Diamond Therapeutics Inc reported initial data from the Phase 1 dose-escalation portion of the Phase 1/2 MasterKey-01 trial evaluating BDTX-189 in patients with advanced solid tumors. Company profile page for Black Diamond Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Wedbush lifts Black Diamond Therapeutics Inc. [BDTX] price estimate. The company, currently valued at $484.58 Million, closed the last trade at $13.4 per share which meant it lost -$0.53 on the day or  … The question becomes, what are the chances the stock … Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) has a beta value of 0 and has seen 4,051,846 shares traded in the last trading session. The relative strength of a dividend stock indicates whether the stock is uptrending or not. Three analysts have made estimates for Black Diamond Therapeutics’ earnings, with the lowest sales estimate coming in at $797.10 million and the highest estimate coming in at $800.75 million. The Black Diamond Therapeutics Inc. stock price fell by -3.05% on the last day (Wednesday, 9th Jun 2021) from $13.12 to $12.72. Jing Jun Ma. Current stock quote for Black Diamond Therapeutics Inc. ( BDTX ) including financial statements, level 2 data, and the latest Biotechnology news, research, and … Black Diamond Therapeutics Inc. (NASDAQ: BDTX) is -18.53% lower on its value in year-to-date trading and has touched a low of $21.04 and a high of $46.25 in the current 52-week trading range. In other Black Diamond Therapeutics news, insider Christopher D. Roberts sold 2,500 shares of the stock in a transaction that occurred on Monday, … 180 Varick Street, 6th Floor New York, NY 10014. 4 Wall Street analysts have issued ratings and price targets for Black Diamond Therapeutics in the last 12 months. Portfolio management news, reports, video and more. Stock analysis for Black Diamond Therapeutics Inc (BDTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. If you had invested in Black Diamond Therapeutics stock at $39.48, your return over the last 1 years would have been -65.5%, for an annualized return of -65.5%. -0.53 (-3.88%) CLOSED AT 4:00 PM ET ON May 28, 2021. Black Diamond Therapeutics employs 69 staff and has a market cap (total outstanding shares value) of 0.00. The Company’s technology platform, Mutation-Allostery-Pharmacology (MAP) platform is designed to allow it to analyze population-level genetic sequencing data to identify oncogenic mutations that promote cancer across tumor types, group these mutations into families and develop a single … Explore commentary on Black Diamond Therapeutics… Black Diamond Therapeutics has a … Black Diamond Therapeutics Inc. is an oncology medicine company. The Cambridge, Massachusetts -based company said it had a loss of 84 cents per share. Is BDTX a Buy, Hold or Sell? Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. Today's IPO for Black Diamond Therapeutics (NASDAQ: BDTX) opened for trading at $33 after pricing 10,586,316 shares of common stock at a public offering price of … It engages in discovery and development of small molecule, tumor-agnostic therapies. Black Diamond Therapeutics Inc is a precision oncology medicine company. BDTX shares have fallen 39.44% over the last 12 months, and they have moved down 20.18% in the past week. View the real-time BDTX price chart on Robinhood and decide if you want to buy or sell commission-free. Get the hottest stocks to trade every day before the market opens 100% free. Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive. Find the latest Black Diamond Therapeutics, Inc (BDTX) stock quote, history, news and other vital information to help you with your stock trading and investing. The stock … The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. is a precision oncology medicine company. 14, 2020 at 9:21 a.m. Company to host conference call on Wednesday, May 19, 2021 at 6:00 PM ET CAMBRIDGE, Mass. The high price target for BDTX is $58.00 and the low price target for BDTX is $45.00. CAMBRIDGE, Mass. Black Diamond targets undrugged mutations in patients with genetically defined cancers. Black Diamond is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry. BDTX is down -$0.74 from the previous closing price of $26.95 on volume of 210,594 shares. The company has … Black Diamond Therapeutics, Inc. is a precision oncology medicine company. Get the hottest stocks to … BDTX stock opened at $26.20 on Wednesday. Black Diamond Therapeutics, Inc., a precision oncology medicine company, discovers and develops small molecule, tumor-agnostic therapies. The stock has a consensus analyst rating of "Buy." During the day, the stock rose to $13.35 an Here is the INSIGHT. $13.12. In other news, insider Christopher D. Roberts sold 2,500 shares of Black Diamond Therapeutics stock in a transaction that occurred on Wednesday, February 3rd. Check out our BDTX stock analysis, current BDTX quote, charts, and historical prices for Black Diamond Therapeutics Inc stock It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. Black Diamond Therapeutics Inc. [NASDAQ: BDTX] stock went on a downward path that fall over -14.79% on Tuesday, amounting to a one-week price decrease of less than -6.86%. Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting. Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) shares, dropped in value on Thursday, May 20, with the stock price down by -37.34% to the previous day’s close as weak demand from buyers trailed the stock to $13.93. Three analysts have made estimates for Black Diamond Therapeutics’ earnings, with the lowest sales estimate coming in at $797.10 million and the highest estimate coming in at $800.75 million. Witnessing the stock’s movement on the chart, on June 09, 2021, Black Diamond Therapeutics Inc. (NASDAQ: BDTX) had a quiet start as it plunged -3.05% to $12.72. CAMBRIDGE, Mass. Click her The key reasons why Black Diamond Therapeutics Inc. (BDTX) is -72.33% away from 52-week high? Financial summary and company information for Black Diamond Therapeutics Inc BDTX Data is currently not available. View detailed financial information, real-time news, videos, quotes and analysis on Black Diamond Therapeutics, Inc. (NASDAQ:BDTX). Black Diamond Therapeutics, Inc. (BDTX) Quote Overview » News » Black Diamond Therapeutics, Inc. ... How Black Diamond Therapeutics (BDTX) Stock Stands Out … The company's lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of … ... Black Diamond Therapeutics Inc. $12.83. Get the latest Black Diamond Therapeutics Inc (BDTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Find the latest news headlines from Black Diamond Therapeutics, Inc. Common Stock (BDTX) at Nasdaq.com. View the latest ratings for BDTX. Nasdaq 100. and has now fallen 3 days in a row.During the day the stock fluctuated 5.28% from a day low at $12.68 to a day high of $13.35.The price has been going up and down for this period, and there has been a -4.22% loss for the last 2 weeks. The company has one pipeline technology platform namely, Mutation-Allostery … Black Diamond Therapeutic Q1 EPS $ (0.84) Down From $ (0.51) YoY Benzinga Newsdesk Fri, 07 May 2021 07:47:48 -0400. Stock Price Prediction: Update at 5:00pm EST Wall Street brokerages predict that Black Diamond Therapeutics (NASDAQ:REYN) will announce $798.38 million in sales for the current quarter, Zacks reports. Find the latest news headlines from Black Diamond Therapeutics, Inc. Common Stock (BDTX) at Nasdaq.com. Black Diamond Therapeutics (BDTX) has an average rating of buy and price targets ranging from $24 to … Get Black Diamond Therapeutics Inc (BDTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. About BDTX. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. $13.16 USD. How has Black Diamond Therapeutics's share price performed over time and what events caused price changes? Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Insiders Increased Their Holdings. Stock market news live updates: ... A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. and NEW YORK, May 19, 2021- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, MasterKey therapies, today announced initial data from the Phase 1 dose-escalation portion of the MasterKey-01 trial of BDTX-189 in patients with advanced solid tumors harboring any … Get the latest Black Diamond Therapeutics, Inc. BDTX detailed stock quotes, stock data, … $13.42. Black Diamond Therapeutics Inc. (NASDAQ:BDTX) went down by -28.48% from its latest closing price compared to the recent 1-year high of $46.25. The company report on January 5, 2021 that Black Diamond Therapeutics to Present at the J.P. Morgan 39th Annual Healthcare Confe It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. 1. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA. Black Diamond Therapeutics Stock Plunges On Safety Signals In Solid Tumor Study Of BDTX-189 Black Diamond Therapeutics Inc (NASDAQ: BDTX) reported initial data from the Phase 1 dose-escalation portion of the Phase 1/2 MasterKey-01 trial evaluating BDTX-189 in patients with advanced solid tumor... 2 weeks ago - Benzinga Company profile. Find real-time BDTX - Black Diamond Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. How Black Diamond Therapeutics (BDTX) Stock Stands Out in a Strong Industry May. Explore commentary on Black Diamond Therapeutics… The firm has a market capitalization of $946.82 million and a PE ratio of -4.33. Get the latest Black Diamond Therapeutics, Inc (BDTX) stock news and headlines to help you in your trading and investing decisions. CAMBRIDGE, Mass. Volume 692,368. Black Diamond Therapeutics Inc. (BDTX) shares plunged 18.58% to trade at $18.1 in the after-market on Wednesday, May 19, 2021. About Black Diamond Therapeutics Inc Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small … Since then, BDTX stock has decreased by 43.4% and is now trading at $12.83. Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. View detailed financial information, real-time news, videos, quotes and analysis on Black Diamond Therapeutics, Inc. (NASDAQ:BDTX). Black Diamond Therapeutics. Considering analysts have assigned the stock a price target range of $24.00-$58.00 as the low and high respectively, we find the trailing 12-month average consensus price target to … The major determining factor in this rating is whether the stock is trading close to its 52-week-high. AFTER HOURS 7:42 PM EDT 06/07/21. and NEW YORK, Dec. 5, 2019 /PRNewswire/ -- Black Diamond Therapeutics… bizjournals.com - Black Diamond Therapeutics Inc., a precision oncology medicine company, has inked a lease for more than 18,000 square feet in Kips Bay. CAMBRIDGE, Mass. Black Diamond Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts. and NEW YORK, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced the presentation of pre-clinical data on the Company’s lead product candidate BDTX-189 at the 32 nd EORTC-NCI-AACR Virtual … Get Black Diamond Therapeutics Inc (BDTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Black Diamond Therapeutics currently has 4 buy ratings from Wall Street analysts. (AP) _ Black Diamond Therapeutics, Inc. (BDTX) on Tuesday reported a loss of $17.9 million in its third quarter. Wedbush Removes Outperform-Rated Black Diamond Therapeutics From Best Ideas List; Price Target is $48 8:11AM ET 5/21/2021 MT Newswires. Barron’s reported 15 min ago that Cancer Biotechs Are on the Move in Advance of Big Conference and NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (NASDAQ: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced the pricing of its initial public offering of 10,586,316 shares of common stock at a public offering price of $19.00 per … Black Diamond Therapeutics, Inc. Common Stock (BDTX) Nasdaq Listed. The company’s stock price has collected -20.18% of loss in the last five trading sessions. dbtnews 6/2/2021. Wedbush raised the price target for the Black Diamond Therapeutics Inc. (NASDAQ:BDTX) stock to “an Outperform”. 0.45 3.54%. Wall Street brokerages predict that Black Diamond Therapeutics (NASDAQ:REYN) will announce $798.38 million in sales for the current quarter, Zacks reports. Black Diamond Therapeutics Inc. (NASDAQ:BDTX) shares, rose in value on Wednesday, June 06, with the stock price down by -3.05% to the previous day’s close as strong demand from buyers drove the stock to $12.72. Black Diamond Therapeutics (NASDAQ: BDTX) shares have tumbled nearly 30% in premarket trading after the company posted early-stage results of … Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Black Diamond Therapeutics against related stocks people have also bought like FIXX, CCXI, HOOK, and ALEC. Description: Black Diamond Therapeutics Inc is a precision oncology medicine company. Alex Mayweg, Ph.D., is founding CSO at Black Diamond. Alex is an accomplished leader in pharmaceutical drug discovery and medicinal chemistry across Europe, the U.S. and Asia. BDTX's rank also includes a long-term technical score of 0. According to TipRanks.com, Burns is a 4-star analyst with an average return of 11.6% and a 41.1% success rate. Posted Nov 23, 2020. Earlier, BDTX’s stock lost 4.63% to close Wednesday’s normal session at $22.23 per share. The company … Black Diamond Therapeutics takes lab, office space at Alexandria Center for Life Science - New York Business Journal - … By Benzinga - Mar 10, 2021. Latest Share Price and Events Stable Share Price : BDTX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week. stock was originally listed at a price of $39.48 in Jan 30, 2020. Black Diamond Therapeutics Closes $85 Million Series C Financing. Black Diamond Therapeutics Inc. BDTX (U.S.: Nasdaq) Black Diamond Therapeutics Inc. AT CLOSE 4:00 PM EDT 06/07/21. Company Description. Who else is bullish? Their average twelve-month price target is $51.50, predicting that the stock has a possible upside of 301.40%. CAMBRIDGE, Mass. The key reasons why Black Diamond Therapeutics Inc. (BDTX) is -72.33% away from 52-week high? Its lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor (EGFR) and tyrosine-protein kinase. As a group, sell-side analysts anticipate that Black Diamond Therapeutics, Inc. will post -2.03 EPS for the current fiscal year. Witnessing the stock’s movement on the chart, on June 09, 2021, Black Diamond Therapeutics Inc. (NASDAQ: BDTX) had a quiet start as it plunged -3.05% to $12.72. Black Diamond Therapeutics, Inc is a biotechnology business based in the US. (BDTX) stock and general news. The results fell short of Wall Street expectations. Stocks similar to Black Diamond Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IMUX, KALA and ELDN. H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Black Diamond Therapeutics (BDTX – Research Report) today and set a price target of $53.00.The company’s shares closed last Wednesday at $22.23, close to its 52-week low of $21.04. CAMBRIDGE, Mass. View today's stock price, news and analysis for Black Diamond Therapeutics Inc. (BDTX). Corporate Headquarters One Main Street, 10th Floor Cambridge, MA 02142. How to buy Black Diamond Therapeutics, Inc. stock on Stash. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $53. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA. Black Diamond Therapeutics, Inc. (BDTX) Shares March Higher, Can It Continue? Black Diamond Therapeutics, Inc. engages in the biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms. This information may help you make smarter investment decisions. Black Diamond Therapeutics Inc is a precision oncology medicine company. Black Diamond Therapeutics' stock was trading at $22.65 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). BDTX : 12.78 (+0.47%) Black Diamond Therapeutics Presents Pre-Clinical Data on Lead Product Candidate BDTX-189 at the 32nd EORTC-NCI-AACR Virtual Symposium GlobeNewswire - Mon Oct 26, 2020. Black Diamond Therapeutics Inc's number of analysts covering the stock is higher than 68.94% of stocks in the small market cap category. The rating was released on January 07, 2021. Black Diamond Therapeutics Inc. [NASDAQ: BDTX] stock went on a downward path that fall over -3.89% on Tuesday, amounting to a one-week price decrease of less than -7.42%. Fact checked.  Black Diamond Therapeutics, Inc. (BDTX) registered a -35.18% downside in the last session and has traded in the red over the past 5 sessions. Black Diamond Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, MasterKey therapies, today announced initial data from the Phase 1 dose-escalation portion of the MasterKey-01 trial of BDTX-189 in patients with advanced solid tumors harboring any one of more than 48 oncogenic alterations in the epidermal … View Black Diamond Therapeutics, Inc. BDTX investment & stock information. Over the past year the S&P 500 is up 17.45% while BDTX is down -33.61%. ET on Zacks.com Black Diamond Therapeutics Inc. Black Diamond Therapeutics, Inc. is … investchronicle 5/31/2021. View Black Diamond Therapeutics, Inc. BDTX investment & stock information. View which stocks have been most impacted by COVID-19. We often see insiders buying up shares in companies that perform well over the long term. Enter the amount you'd like to invest in Black Diamond Therapeutics, Inc. stock, then proceed to checkout. The 1-year high price for the company’s stock is recorded $37.76 on 01/12/21, with the lowest value was $12.89 for the same time period, recorded on 05/26/21. Black Diamond Therapeutics Inc (BDTX) stock is lower by -2.75% while the S&P 500 is higher by 0.13% as of 11:25 AM on Thursday, Jan 21. Black Diamond Therapeutics Announces Appointment of Oncology.. 1/11/2021: 17:59: EDGAR: Statement of Changes in Beneficial Ownership (4) 1/06/2021: 18:28: EDGAR: Statement of … CAMBRIDGE, Mass. The stock’s 5-day price performance is -44.88%, and it has moved by -39.83% in 30 days. Black Diamond Therapeutics Inc. (NASDAQ: BDTX) stock closed at 12.83 per share at the end of the most recent trading day (a 1.34 % change compared to the prior day closing price) with a volume of 862.55K shares and market capitalization of 463.96M.Is a component of indices and it is traded on NASDAQ exchange. ";s:7:"keyword";s:37:"black diamond therapeutics stock news";s:5:"links";s:1086:"<a href="https://api.duassis.com/storage/q8q7nfc/high-pressure-pta-balloon-catheter">High Pressure Pta Balloon Catheter</a>,
<a href="https://api.duassis.com/storage/q8q7nfc/delonghi-parts-canada">Delonghi Parts Canada</a>,
<a href="https://api.duassis.com/storage/q8q7nfc/how-many-hours-internship-for-credit">How Many Hours Internship For Credit</a>,
<a href="https://api.duassis.com/storage/q8q7nfc/lucky-duck-riot-e-caller">Lucky Duck Riot E Caller</a>,
<a href="https://api.duassis.com/storage/q8q7nfc/harlan-hill-education">Harlan Hill Education</a>,
<a href="https://api.duassis.com/storage/q8q7nfc/cancer-survivor-grants">Cancer Survivor Grants</a>,
<a href="https://api.duassis.com/storage/q8q7nfc/dollar%2C-slangily-crossword-clue">Dollar, Slangily Crossword Clue</a>,
<a href="https://api.duassis.com/storage/q8q7nfc/restaurant-logo-design">Restaurant Logo Design</a>,
<a href="https://api.duassis.com/storage/q8q7nfc/sushi-yasaka-michelin">Sushi Yasaka Michelin</a>,
<a href="https://api.duassis.com/storage/q8q7nfc/principles-of-kinesiology">Principles Of Kinesiology</a>,
";s:7:"expired";i:-1;}

Zerion Mini Shell 1.0